Section 3. Definitions

3. Definitions.— In this Act, unless the context otherwise requires, — 5 [(a) "appointed day", in relation to an Institute mentioned in column (3) of the Schedule, means the date of its establishment as mentioned against it in column (4) of that Schedule;] (b) "Board" means the Board of Governors of[6] [an Institute] constituted under sub-section (3) of section 4; (c) "Chairperson" means the Chairperson of[6] [an Institute] nominated under clause (a) of sub-section (3) of section (4); 7[(ca) "Council" means the Council established under sub-section (1) of section 30A;] (d) "Dean" means the Dean of[6] [an Institute] appointed under section 17; (e) "Director" means the Director of[6] [an Institute] appointed under section 16; (f) "Fund" means the fund of[6] [an Institute] to be maintained under section 21; 8[(g) "Institute" means any of the institutions mentioned in column (3) of the Schedule; (ga) "member" means a member of the Council nominated or elected under sub-section (2) of section 30A; (gb) "prescribed" means prescribed by rules made under this Act; (gc) "Schedule" means the Schedule to this Act;] (h) "Senate" means the Senate of[6] [an Institute] referred to in section 13; 1. Subs. by Act 43 of 2021, s. 2 for Long title (w.e.f. 25-5-2022). 2. Subs. by s. 3, ibid., for "Institute" (w.e.f. 25-5-2022). 3. 8th July, 1998, vide notification No. S.O. 1412(E), dated 7th July, 1998, see Gazette of India, Extraordinary, Part II, sec. 3(ii). 4. Subs. by Act 43 of 2021, s. 4, for section 2 (w.e.f. 25-5-2022). 5. Subs. by s. 5, ibid ., for clause (a) (w.e.f. 25-5-2022). 6. Subs. by s. 5, ibid., for "the Institute" (w.e.f. 25-5-2022). 7. Ins. by s. 5, ibid . (w.e.f. 25-5-2022). 8. Subs. by s. 5, ibid ., for clause (g) (w.e.f. 25-5-2022). (i) "Society" means the National Institute of Pharmaceutical Education and Research Society, Sector-67, S.A.S. Nagar (Mohali), District Ropar, Punjab registered under the Societies Registration Act, 1860 (21 of 1860); (j) "Statutes" and "Ordinances" mean the Statutes and the Ordinances of[1] [an Institute] made under this Act. ==> picture [64 x 13] intentionally omitted <== THE INSTITUTE 2[4. Establishment and incorporation of Institutes.]—3 [(1) Each of the Institutes mentioned in column (3) of the Schedule shall be a body corporate.] (2)[4] [Each Institute] shall have perpetual succession and a common seal with power, subject to the provisions of this Act, to acquire, hold and dispose of property and to contract, and shall, by that name, sue and be sued. 5[(2A) The Central Government may, by notification in the Official Gazette, establish similar Institutes in different parts of the country.] 6[(3) The Board of Governors of an Institute shall consist of the following persons, namely:— (a) a Chairperson, who shall be an eminent academician or scientist or technologist or professional, to be nominated by the Visitor; (b) the Director of the institute, ex officio ; (c) the Joint Secretary to the Government of India in Department of Pharmaceuticals dealing with the national institutes of pharmaceutical education and research, ex officio ; (d) the Secretary, dealing with medical or technical education in the State Government concerned, ex officio ; (e) the representative of Drug Controller General of India, Ministry of Health and Family Welfare of the Government of India, ex officio ; (f) three eminent pharmaceutical experts, at least one of whom shall be a woman, having special knowledge or practical experience in education, research and biotechnology, to be nominated by the Council; (g) two pharmaceutical industrialists to be nominated by the Council; (h) two professors of the institute, to be nominated by the Senate: Provided that one member from amongst members to be nominated under clauses (f), (g) and (h) shall be either from the Scheduled Castes or from the Scheduled Tribes.] (4) The term of office of the Chairperson and Governors other than ex officio Governors shall be three years and they shall be entitled for such allowances as may be determined by the Central Government. 7* * * * * (5) The term of office of Governor nominated to fill a casual vacancy shall continue for the remainder of the term of the Governor in whose place he has been nominated. (6) The Board shall meet at least three times in a year at such place and time and observe such rules of procedure in regard to the transaction of business at its meetings as may be determined by the Board. 1. Subs. by Act 43 of 2021, s. 5, for "the Institute" (w.e.f. 25-5-2022). 2. Subs. by s. 6, ibid ., for marginal heading (w.e.f. 25-5-2022). 3. Subs. by s. 6, ibid ., for sub-section (1) (w.e.f. 25-5-2022). 4. Subs. by s. 6, ibid ., for "The Institute" (w.e.f. 25-5-2022). 5. Ins. by Act 19 of 2007, s. 3 (w.e.f. 29-1-2007). 6. Subs. by Act 43 of 2021, s. 6, for sub-section (3) (w.e.f. 25-5-2022). 7. Proviso omitted by s. 6, ibid . (w.e.f. 25-5-2022).